Source: NEWSMAKER

Press Release: Ethicor Pharma : Phrixus Pharmaceuticals Receives Services From National Institutes of Health, NHLBI SMARTT Program to Produce Carmeseal-MD(TM) for Clinical Trial to Treat Duchenne Muscular Dystrop

...

Read full article »
Ethicor Pharma's Competitors | Ethicor Pharma's News | Ethicor Pharma's Financials
Stay up-to-date with the latest news on Ethicor Pharma
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Richard Drury

CEO Approval Rating

74/100

Read more
Stay up-to-date with the latest news on Ethicor Pharma